{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T01:49:24Z","timestamp":1786585764833,"version":"build-2736575974"},"reference-count":23,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.3892\/mmr.2017.7288","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T06:32:58Z","timestamp":1503037978000},"page":"5338-5346","source":"Crossref","is-referenced-by-count":9,"title":["Sanggenon C protects against pressure overload-induced cardiac hypertrophy via the calcineurin\/NFAT2 pathway"],"prefix":"10.3892","volume":"16","author":[{"given":"Lili","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Shangguan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,8,18]]},"reference":[{"key":"key20180108003409_b1-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"key20180108003409_b2-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","article-title":"Pathophysiology of cardiac hypertrophy and heart failure: Signaling pathways and novel therapeutic targets","volume":"89","author":"Tham","year":"2015","journal-title":"Arch Toxicol"},{"key":"key20180108003409_b3-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies","volume":"128","author":"Bernardo","year":"2010","journal-title":"Pharmacol Ther"},{"key":"key20180108003409_b4-mmr-16-04-5338","first-page":"505","article-title":"Calcium dependent signaling in cardiac hypertrophy and cell death","volume":"23","author":"Nakayama","year":"2013","journal-title":"Clin Calcium"},{"key":"key20180108003409_b5-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/HYPERTENSIONAHA.116.07140","article-title":"Positive role for a negative calcineurin regulator in cardiac hypertrophy","volume":"67","author":"Gao","year":"2016","journal-title":"Hypertension"},{"key":"key20180108003409_b6-mmr-16-04-5338","first-page":"1315","article-title":"Sanggenon C decreases tumor cell viability associated with proteasome inhibition","volume":"3","author":"Huang","year":"2011","journal-title":"Front Biosci (Elite Ed)"},{"key":"key20180108003409_b7-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/08923973.2011.580755","article-title":"Sanggenon C and O inhibit NO production, iNOS expression and NF-\u03baB activation in LPS-induced RAW264.7 cells","volume":"34","author":"Dat","year":"2012","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"key20180108003409_b8-mmr-16-04-5338","first-page":"138","article-title":"Inhibitory effect and mechanism of action of sanggenon C on human polymorphonuclear leukocyte adhesion to human synovial cells","volume":"23","author":"Li","year":"2002","journal-title":"Acta Pharmacol Sin"},{"key":"key20180108003409_b9-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108003409_b10-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2007-969961","article-title":"Constituents of the Chinese crude drug \u2018S\u0101ng-B\u00e1i-P\u00ed\u2019 (morus root bark)","volume":"47","author":"Nomura","year":"1983","journal-title":"Planta Med"},{"key":"key20180108003409_b11-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.phymed.2003.09.005","article-title":"Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L, Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai","volume":"11","author":"Sohn","year":"2004","journal-title":"Phytomedicine"},{"key":"key20180108003409_b12-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/01.RES.0000072977.86706.23","article-title":"Roles of cardiac transcription factors in cardiac hypertrophy","volume":"92","author":"Akazawa","year":"2003","journal-title":"Circ Res"},{"key":"key20180108003409_b13-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pharmthera.2012.06.006","article-title":"Regression of pathological cardiac hypertrophy: Signaling pathways and therapeutic targets","volume":"135","author":"Hou","year":"2012","journal-title":"Pharmacol Ther"},{"key":"key20180108003409_b14-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCRESAHA.110.228452","article-title":"Reversibility of adverse, calcineurin-dependent cardiac remodeling","volume":"109","author":"Berry","year":"2011","journal-title":"Circ Res"},{"key":"key20180108003409_b15-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1128\/IAI.01569-14","article-title":"Nuclear factor of activated T cells regulates neutrophil recruitment, systemic inflammation, and T-cell dysfunction in abdominal sepsis","volume":"82","author":"Zhang","year":"2014","journal-title":"Infect Immun"},{"key":"key20180108003409_b16-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cardiores.2004.04.002","article-title":"Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes","volume":"63","author":"Fiedler","year":"2004","journal-title":"Cardiovasc Res"},{"key":"key20180108003409_b17-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardiores.2004.01.021","article-title":"Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs","volume":"63","author":"Molkentin","year":"2004","journal-title":"Cardiovasc Res"},{"key":"key20180108003409_b18-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1747-0285.2006.00360.x","article-title":"A cell-permeable NFAT inhibitor peptide prevents pressure-overload cardiac hypertrophy","volume":"67","author":"Kuriyama","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"key20180108003409_b19-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00395-011-0166-z","article-title":"Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis","volume":"106","author":"Schneider","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"key20180108003409_b20-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac eibrosis: The fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ Res"},{"key":"key20180108003409_b21-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/14779072.2013.839942","article-title":"Investigational drugs targeting cardiac fibrosis","volume":"12","author":"Roubille","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"key20180108003409_b22-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCRESAHA.116.305381","article-title":"Getting to the heart of the matter: New insights into cardiac fibrosis","volume":"116","author":"Leask","year":"2015","journal-title":"Circ Res"},{"key":"key20180108003409_b23-mmr-16-04-5338","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell Mol Life Sci"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T20:14:44Z","timestamp":1515356084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,18]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,8,18]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.3892\/mmr.2017.7288"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7288","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,18]]}}}